Inventor · disambiguated record
Charles D. Blizzard
Also filed as: BLIZZARD CHARLES · BLIZZARD CHARLES D
24 granted patents·29 pending applications·1,545 citations·filing 1996–2025
96Inventor score
Files withOCULAR THERAPEUTIX INC26INCEPT LLC10CIVITAS THERAPEUTICS INC6EPIC THERAPEUTICS INC4ADVANCED INHALATION RES INC2
Top patents by PatentIndex Score
53 records- 0197US8563027B2Drug delivery through hydrogel plugsINCEPT LLC·Filed 2013·Granted Oct 22, 2013·48 cites·31 claims
- 0297US8409606B2Drug delivery through hydrogel plugsSAWHNEY AMARPREET S·Filed 2010·Granted Apr 2, 2013·69 cites·23 claims
- 0396US11331267B2Sustained release biodegradable intracanalicular inserts comprising a hydrogel and cyclosporineOCULAR THERAPEUTIX INC·Filed 2021·Granted May 17, 2022·5 cites·23 claims
- 0496US11291627B1Sustained release biodegradable intracanalicular inserts comprising a hydrogel and cyclosporineOCULAR THERAPEUTIX INC·Filed 2021·Granted Apr 5, 2022·6 cites·23 claims
- 0596US10786462B2Shape changing drug delivery devices and methodsINCEPT LLC·Filed 2019·Granted Sep 29, 2020·25 cites·24 claims
- 0696US10420724B2Shape changing drug delivery devices and methodsINCEPT LLC·Filed 2016·Granted Sep 24, 2019·29 cites·25 claims
- 0796US6268053B1Macromolecular microparticles and methods of production and useEPIC THERAPEUTICS INC·Filed 2000·Granted Jul 31, 2001·240 cites·10 claims
- 0896US6090925AMacromolecular microparticles and methods of production and useEPIC THERAPEUTICS INC·Filed 1996·Granted Jul 18, 2000·432 cites·73 claims
- 0996US5981719AMacromolecular microparticles and methods of production and useEPIC THERAPEUTICS INC·Filed 1998·Granted Nov 9, 1999·385 cites·15 claims
- 1095US11534396B2Methods of treatment with an ocular implant containing a tyrosine kinase inhibitorOCULAR THERAPEUTIX INC·Filed 2022·Granted Dec 27, 2022·9 cites·29 claims
- 1195US6458387B1Sustained release microspheresEPIC THERAPEUTICS INC·Filed 1999·Granted Oct 1, 2002·266 cites·28 claims
- 1294US12161753B2Sustained release biodegradable intracanalicular inserts comprising a hydrogel and an active agentOCULAR THERAPEUTIX INC·Filed 2021·Granted Dec 10, 2024·2 cites·26 claims
- 1394US11439592B2Ocular implant containing a tyrosine kinase inhibitorOCULAR THERAPEUTIX INC·Filed 2021·Granted Sep 13, 2022·6 cites·27 claims
- 1493US11622935B2Methods of treating ocular diseases using polyalkylene glycol intracameral implants with polyactide travoprost particlesOCULAR THERAPEUTIX INC·Filed 2022·Granted Apr 11, 2023·2 cites·2 claims
- 1592US11779536B2Sustained release biodegradable intracanalicular inserts comprising a hydrogel and cyclosporineOCULAR THERAPEUTIX INC·Filed 2022·Granted Oct 10, 2023·1 cites·20 claims
- 1692US11369591B2Drug delivery from hydrogelsINCEPT LLC·Filed 2016·Granted Jun 28, 2022·5 cites·21 claims
- 1790US12357565B2Ocular implant containing a tyrosine kinase inhibitorOCULAR THERAPEUTIX INC·Filed 2022·Granted Jul 15, 2025·1 cites·10 claims
- 1885US8614255B2Pulmonary pharmaceutical formulationsBLIZZARD CHARLES D·Filed 2008·Granted Dec 24, 2013·14 cites·19 claims
- 1985US2025057759A1Sustained release biodegradable intracanalicular inserts comprising a hydrogel and cyclosporineOCULAR THERAPEUTIX INC·Filed 2024·Application pending·0 cites
- 2084US12109302B2Sustained release biodegradable intracanalicular inserts comprising a hydrogel and cyclosporineOCULAR THERAPEUTIX INC·Filed 2023·Granted Oct 8, 2024·0 cites·20 claims
- 2181US12329853B2Compositions and methods for treating ocular diseasesOCULAR THERAPEUTIX INC·Filed 2022·Granted Jun 17, 2025·0 cites·20 claims
- 2281US2025144012A1Intracameral drug delivery depotsINCEPT LLC·Filed 2024·Application pending·0 cites
- 2380US11938223B2Shape changing drug delivery devices and methodsINCEPT LLC·Filed 2022·Granted Mar 26, 2024·0 cites·20 claims
- 2480US2024285518A1Ocular hydrogel tyrosine kinase inhibitor implantsOCULAR THERAPEUTIX INC·Filed 2024·Application pending·0 cites
- 2578US2025268818A1Compositions and methods for treating ocular diseasesOCULAR THERAPEUTIX INC·Filed 2025·Application pending·0 cites
- 2677US2025120906A1Sustained release biodegradable intracanalicular inserts comprising a hydrogel and an active agentOCULAR THERAPEUTIX INC·Filed 2024·Application pending·0 cites
- 2775US2023040637A1Ocular hydrogel tyrosine kinase inhibitor implantsOCULAR THERAPEUTIX INC·Filed 2022·Application pending·0 cites
- 2874US2022401356A1Intracameral drug delivery depotsINCEPT LLC·Filed 2022·Application pending·0 cites
- 2974US2025332094A1Ocular implant containing a tyrosine kinase inhibitorOCULAR THERAPEUTIX INC·Filed 2025·Application pending·0 cites
- 3073US2024165018A1Hydrogel implants for lowering intraocular pressureOCULAR THERAPEUTIX INC·Filed 2023·Application pending·0 cites
- 3172US2022296559A1Composition of a Spray-Dried Powder for Pulmonary Delivery of a Long Acting Neuraminidase Inhibitor (LANI)CIVITAS THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 3271US11413250B2Shape changing drug delivery devices and methodsINCEPT LLC·Filed 2020·Granted Aug 16, 2022·0 cites·14 claims
- 3371US2022296612A1Pulmonary pharmaceutical formulationsCIVITAS THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 3470US2023285282A1Ocular implant containing an active ingredientOCULAR THERAPEUTIX INC·Filed 2023·Application pending·0 cites
- 3569US2022370419A1Drug delivery from hydrogelsINCEPT LLC·Filed 2022·Application pending·0 cites
- 3669US2021251893A1Compositions and Methods for Treating Ocular DiseasesOCULAR THERAPEUTIX INC·Filed 2021·Application pending·0 cites
- 3766US12171869B2Intracameral drug delivery depotsINCEPT LLC·Filed 2017·Granted Dec 24, 2024·0 cites·26 claims
- 3866US2019022053A1Composition of a Spray-Dried Powder for Pulmonary Delivery of a Long Acting Neuraminidase Inhibitor (LANI)CIVITAS THERAPEUTICS INC·Filed 2018·Application pending·0 cites
- 3965US2020337989A1Ocular hydrogel tyrosine kinase inhibitor implantsOCULAR THERAPEUTIX INC·Filed 2020·Application pending·0 cites
- 4064US12453724B2Ocular implant containing a tyrosine kinase inhibitorOCULAR THERAPEUTIX INC·Filed 2025·Granted Oct 28, 2025·0 cites·12 claims
- 4164US2023390189A1Ocular implant containing an active ingredientOCULAR THERAPEUTIX INC·Filed 2021·Application pending·0 cites
- 4262US2025114373A1Intracanalicular insert comprising an antimicrobial agentOCULAR THERAPEUTIX INC·Filed 2023·Application pending·0 cites
- 4362US2017007571A1Composition of a Spray-Dried Powder for Pulmonary Delivery of a Long Acting Neuraminidase Inhibitor (LANI)CIVITAS THERAPEUTICS INC·Filed 2016·Application pending·0 cites
- 4461US2025064760A1Intracanalicular insert comprising a non-steroidal anti-inflammatory agentOCULAR THERAPEUTIX INC·Filed 2023·Application pending·0 cites
- 4560US2008063722A1Composition of a Spray-Dried Powder for Pulmonary Delivery of a Long Acting Neuraminidase Inhibitor (LANI)ADVANCED INHALATION RES INC·Filed 2007·Application pending·0 cites
- 4659US2016151393A1Pulmonary pharmaceutical formulationsCIVITAS THERAPEUTICS INC·Filed 2015·Application pending·0 cites
- 4757US2014148424A1Pulmonary Pharmaceutical FormulationsCIVITAS THERAPEUTICS INC·Filed 2013·Application pending·0 cites
- 4856US2020337990A1Hydrogel implants for lowering intraocular pressureOCULAR THERAPEUTIX INC·Filed 2020·Application pending·0 cites
- 4955US2022183969A1Ocular insert containing a glucocorticoidOCULAR THERAPEUTIX INC·Filed 2021·Application pending·0 cites
- 5054US2003059474A1Sustained release microspheresFiled 2002·Application pending·0 cites
Showing the top 50 of 53 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Charles D. Blizzard files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →